bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 10 citations · 31 references
Life SciencesCancer BiologyCell BiologyMolecular OncologyTranscriptomicsTumor MicroenvironmentCancer TranscriptomicsSingle-cell Rna Sequencing AnalysisSingle-cell TranscriptomicsSpatial TranscriptomicsTherapeutic ResistanceTumor Immune MicroenvironmentCancer Cell-intrinsic Immune ResistanceImmune Gene Expression SignaturesIntrinsic Resistance RegulationMicroenvironmental AlterationsMicroenvironmental CuesSingle-cell Rna SequencingTherapeutic Resistance MechanismsTumor Microenvironment-mediated Resistance
Abstract Resistance to cancer therapy is driven by both cell-intrinsic and microenvironmental factors. We use spatial transcriptomics and single-cell RNA sequencing to uncover distinct resistance programs in melanoma cells shaped by intrinsic cellular states and the tumor microenvironment. Consensus non-negative matrix factorization reveals shared intrinsic resistance programs across cell lines. In patient samples, these resistance programs coexist within individual tumors and associate with diverse immune signatures. Single-cell resolution spatial transcriptomics in xenograft models reveals both intrinsically determined and extrinsically influenced resistant fates. This work demonstrates that therapy-resistant fates coexist within distinct microenvironments and that tissue features influence which fate is adopted.
31
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma, Diana Lee, Bihua Li et al. · Cell · 2010 · 2.8K citations · Full text
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta, Christine M. Fillmore, Guozhi Jiang et al. · Cell · 2011 · 1.5K citations · Full text
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco et al. · Cell · 2018 · 1.4K citations · Full text
Medicine, Cancer Biology, Oncology +12
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer, Margaret C. Dunagin, Stefan Torborg et al. · Nature · 2017 · 1.3K citations
Medicine, Cancer Biology, Oncology +16